SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001044321-03-000003
Filing Date
2003-01-09
Accepted
2003-01-09 16:31:16
Documents
1
Group Members
AUSTIN W. MARXEAWM INVESTMENT COMPANY, INC.DAVID M. GREENHOUSEMG ADVISERS, L.L.C.MGP ADVISERS LIMITED PARTNERSHIPSPECIAL SITUATIONS CAYMAN FUND, L.P.SPECIAL SITUATIONS FUND III, L.P.SPECIAL SITUATIONS PRIVATE EQUITY FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 intl13gt.txt SC 13G/A 16790
  Complete submission text file 0001044321-03-000003.txt   19171
Mailing Address 153 EAST 53RD STREET 51ST FLOOR NEW YORK NY 10022
Business Address 153 E 53 ST 51ST FL NEW YORK NY 10022 2128325300
SPECIAL SITUATIONS FUND III L P (Filed by) CIK: 0000914248 (see all company filings)

IRS No.: 133737427 | State of Incorp.: DE | Fiscal Year End: 1231

Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Subject) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-53249 | Film No.: 03509381
SIC: 2835 In Vitro & In Vivo Diagnostic Substances